Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
Oil weakness and a tech-led stock rally push the VIX toward the 17 level as traders return to equities.
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
Bitcoin tumbled to fresh weekly lows as on-chain metrics show long-term holders under pressure and exchange inflows r...
As inflation data looms and policy bets swirl, investors ask whether does president trump’s bull market start up agai...
Microsoft stock price prediction signals potential upside as AI and cloud demand drive earnings; investors weigh risk...
Sen. Bernie Sanders rolls out a blueprint for public ownership of AI firms and a $1,000 annual payout to Americans, a...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
Amazon's latest earnings highlighted a bold AI bet and a hefty capex agenda. This article breaks down what it means f...
Broadcom is slated to report fiscal Q2 results after the market closes today, with investors focusing on AI-driven re...